Goldline Pharmaceutical was originally incorporated on August 2, 2004, as a private limited company in the name of ‘Goldline Pharmaceutical Private Limited’ under the provisions of the Companies Act, 1956 with the Registrar of Companies, Maharashtra at Mumbai. Subsequently pursuant to a special resolution passed by its Shareholders in the Extra-Ordinary General Meeting held on July 18, 2013, the company was converted from a private limited company into a public limited company and consequently, the name of the company was changed to ‘Goldline Pharmaceutical Limited’ and a fresh certificate of incorporation dated September 23, 2013 was issued by the Registrar of Companies, Maharashtra at Mumbai.

Goldline Pharmaceutical is engaged in the business of marketing pharmaceutical products under the brand name ‘Goldline’. The products sold under the ‘Goldline’ brand are categorized into five segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed by the company are not manufactured by the company. Instead, it enters into agreements with third-party manufacturers who produce these products for the company. The order for manufacturing to third party is based on market research and analysis. These manufacturers operate under specific contractual arrangements, ensuring that the products meet the requisite standards and specifications. Once the products are manufactured, it sells them under its brand name ‘Goldline’. 

Its customers primarily include distributors, who may further categorize as retailers and wholesalers. These distributors form the main channel through which its products reach the end-users. It maintains contractual and business arrangements with the manufacturers to ensure a consistent supply of products for marketing and sale under its brand name. It has established contractual arrangements, with manufacturers for the production of its pharmaceutical products and distributors for marketing and selling.

Business area of the company

Goldline Pharmaceutical is engaged in the business of marketing pharmaceutical products under the Goldline brand. Its products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. Its primary customers are distributors, who are further categorized as retailers and wholesalers. These distributors serve as the key channel through which its products reach the end-users.

Company's product categories

• Goldline Pharma: This category includes 42 products designed to cater to specialties such as Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology.
• Goldline Cardinal: This category comprises 54 products tailored for the Specialty division, serving medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians.
• Goldline Aayushman: This category comprises 18 products designed for the Specialty division, catering to medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners.
• Goldline In Life: This category includes 22 products tailored for the Specialty division, serving Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians.
• Goldline Wellness: This category includes 10 products tailored Supportive care plays a crucial role in cancer therapy, aiming to enhance the quality of life while patients endure the challenges of the disease.

History and milestones

• 2004: Incorporation of the company as a private company under the name ‘Goldline Pharmaceutical Private Limited.’ 
• 2013: Conversion of the company from a private limited company to a public company and the new name of company as ‘Goldline Pharmaceutical Limited.’

Awards, accreditations and recognitions

• 2014: In recognition of its immense participation in organising the 1st world congress of Coloproctology, it was awarded with a certificate of participation by the organisation secretaries of International Society of Coloproctologists.
• 2015: In recognition of its immense participation in the 5th International CME in Gastroenterology & Hepatology, it was awarded with a certificate of participation by the Midas Medical Foundation & Research Institute, Nagpur.
• 2018: In recognition of its immense participation in the Conference on Gastroenterology & Hepatology, it was awarded with a certificate of participation by the Midas Medical Foundation & Research Institute, Nagpur.
• 2018: In recognition of its immense participation in the Trade Exhibition of Gastrocon, it was awarded with the Best Stall award by the Midas Medical Foundation & Research Institute, Nagpur.
• 2019: In recognition of its immense participation in the 14th International Conference of Association of Minimal Access Surgeons of India, it was awarded with a Best Stall & Trade Partner Award by the organising committee of 14th International Conference of Association of Minimal Access Surgeons of India.
• 2024: In recognition of its immense participation in organising the Midterm CME, it was awarded with a certificate of valuable contribution by the API Sambalpur City Branch, Deogarh in Association with the Association of Physicians of India.
• 2025: In recognition of its immense participation for the contribution by way of sponsorship in organising the Midas Liver Meet, 2025, it was awarded with a certificate of participation by the organising committee of Midas Liver Meet 2025.